Holen Sie sich die Stockscreener-App
143.19
0.85%
1.1924
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$142.00
Offen:
$141.78
24-Stunden-Volumen:
508.82K
Relative Volume:
0.37
Marktkapitalisierung:
$27.91B
Einnahmen:
$16.51B
Nettoeinkommen (Verlust:
$2.15B
KGV:
13.54
EPS:
10.5771
Netto-Cashflow:
$2.22B
1W Leistung:
-5.45%
1M Leistung:
-7.95%
6M Leistung:
-8.51%
1J Leistung:
-3.06%
1-Tages-Spanne:
$141.72
$144.80
1-Wochen-Bereich:
$141.06
$152.91
52-Wochen-Spanne:
$138.82
$177.66
Raymond James Financial Inc Stock (RJF) Company Profile
Firmenname
Raymond James Financial Inc
Sektor
Branche
Telefon
727-567-1000
Adresse
880 CARILLON PKWY, ST PETERSBURG, FL
Compare RJF vs BLK, BX, BN, KKR, BAM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RJF
Raymond James Financial Inc
|
143.19 | 27.67B | 16.51B | 2.15B | 2.22B | 10.58 |
BLK
Blackrock Inc
|
1,056.64 | 162.45B | 26.28B | 6.75B | 3.76B | 38.77 |
BX
Blackstone Inc
|
116.71 | 141.87B | 14.88B | 6.10B | 869.79M | 3.8977 |
BN
Brookfield Corp
|
45.98 | 102.92B | 77.61B | 4.06B | -8.36B | 0.497 |
KKR
Kkr Co Inc
|
96.65 | 84.43B | 22.38B | 5.74B | 8.54B | 2.9339 |
BAM
Brookfield Asset Management Ltd
|
48.89 | 78.26B | 5.07B | 2.48B | 2.37B | 1.5532 |
Raymond James Financial Inc Stock (RJF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-28 | Eingeleitet | Barclays | Overweight |
| 2025-12-11 | Fortgesetzt | UBS | Neutral |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-04-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-01-06 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-09 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-09-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-01-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-04 | Eingeleitet | TD Cowen | Market Perform |
| 2024-01-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-19 | Eingeleitet | JP Morgan | Neutral |
| 2023-09-11 | Eingeleitet | BofA Securities | Buy |
| 2023-07-21 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-12-19 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-11-22 | Eingeleitet | UBS | Neutral |
| 2022-10-19 | Eingeleitet | Credit Suisse | Neutral |
| 2022-10-12 | Eingeleitet | Citigroup | Neutral |
| 2022-01-28 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2022-01-10 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-07-21 | Eingeleitet | Jefferies | Buy |
| 2021-01-15 | Hochstufung | Wells Fargo | Underweight → Overweight |
| 2021-01-05 | Hochstufung | Goldman | Sell → Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Neutral |
| 2020-06-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-01 | Herabstufung | Compass Point | Buy → Neutral |
| 2020-03-25 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-03-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-24 | Herabstufung | Goldman | Neutral → Sell |
| 2020-03-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-04 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-03-06 | Eingeleitet | Argus | Buy |
| 2018-11-27 | Eingeleitet | Goldman | Neutral |
| 2018-10-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-27 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2018-07-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-05-16 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-27 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-04-10 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-02-27 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
Alle ansehen
Raymond James Financial Inc Aktie (RJF) Neueste Nachrichten
Raymond James downgrades Caesars Entertainment stock rating on acquisition deal - Investing.com Canada
Analysts Are Bullish on These Financial Stocks: Raymond James Financial (RJF), Invesco (IVZ) - The Globe and Mail
Raymond James initiates GBank Financial stock with outperform rating - Investing.com
Raymond James Adjusts PT on Dell Technologies to $500 From $182, Maintains Outperform Rating - marketscreener.com
Raymond James cuts SentinelOne stock rating on execution concerns By Investing.com - Investing.com India
Allstate Corp Raises Stake in Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James Raises its Price Target on Analog Devices (ADI) - Yahoo Finance
Advisor moves: Raymond James picks up $2.8B team of 24 while LPL, NewEdge expand advisor headcount - InvestmentNews
Raymond James initiates Mechanics Bancorp stock at Outperform By Investing.com - Investing.com Canada
Raymond James Raises Spotify (SPOT) Price Target on AI-Driven Growth Strategy - Insider Monkey
Raymond James Recruits $2.8B Team From Commonwealth - Yahoo Finance
TD Cowen lowers Raymond James stock price target on earnings outlook - Investing.com
Raymond James Downgrades RLJ Lodging Trust to Outperform From Strong Buy, Adjusts PT to $11 From $9 - marketscreener.com
Raymond James raises Marvell stock price target to $235 on data center strength - Investing.com Nigeria
Raymond James raises Snowflake stock price target on AI momentum By Investing.com - Investing.com Australia
TD Cowen Adjusts PT on Raymond James Financial to $155 From $159, Maintains Hold Rating - marketscreener.com
Raymond James downgrades RLJ Lodging Trust stock rating on valuation By Investing.com - Investing.com Canada
Legal & General Group Plc Has $191.33 Million Stake in Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James Financial, Inc. $RJF Shares Purchased by AlphaQuest LLC - MarketBeat
A Look at Raymond James Financial Inc (RJF) After 4.4% Decline -- GF Value $165.31 vs Price $145.40 - GuruFocus
Raymond James Financial Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Raymond James sees modest Memorial Day mattress sales growth By Investing.com - Investing.com Nigeria
German American Bank Awarded Raymond James Community Bankers Cup for 2025 Performance - marketscreener.com
Raymond James Financial Drops 5.8% Amid Sector-Wide Selling - AlphaStreet
Raymond James reiterates Strong Buy on Biohaven stock after positive drug trial data - Investing.com Australia
Raymond James Financial (RJF) Announces Annual Analyst & Investo - GuruFocus
Raymond James reiterates Market Perform on Bath & Body Works stock - Investing.com
Raymond James Financial holds 2026 Analyst & Investor Day, outlines growth, tech and capital priorities - TradingView
Raymond James (NYSE: RJF) details revenue growth, tech spend and return targets - Stock Titan
Raymond James Cuts Price Target on AutoZone to $4,000 From $4,600, Maintains Strong Buy Rating - marketscreener.com
Raymond James cuts AutoZone stock price target on softer comps - Investing.com
Raymond James cuts AutoZone stock price target on softer comps By Investing.com - Investing.com Canada
Raymond James raises Flywire stock price target on growth outlook - Investing.com
Swedbank AB Increases Position in Raymond James Financial, Inc. $RJF - MarketBeat
Analysts Conflicted on These Financial Names: Raymond James Financial (RJF) and Progressive (PGR) - The Globe and Mail
Raymond James Financial (RJF) down 2% since last earnings report: Can it rebound? - MSN
BridgeBio Pharma Shares Fall After Raymond James Downgrade - Moomoo
APA Maintains Rating by Raymond James -- Price Target Raised to $57 - GuruFocus
Tectonic Therapeutic Shares Rise After Raymond James Upgrade - Moomoo
BBIO Downgraded by Raymond James -- Rating Changed to Market Per - GuruFocus
Barclays Maintains Raymond James Financial(RJF.US) With Buy Rating, Maintains Target Price $182 - Moomoo
BridgeBio Pharma (BBIO) Downgraded by Raymond James Amid Competitive Pressures - GuruFocus
BridgeBio stock downgraded at Raymond James (PFE:NYSE) - Seeking Alpha
Raymond James Downgrades BridgeBio Pharma(BBIO.US) to Hold Rating - Moomoo
Raymond James raises Viper Energy stock price target on acquisition - Investing.com
Raymond James Adjusts PT on Cummins to $745 From $675, Maintains Outperform Rating - Moomoo
Raymond James Adjusts Price Target on APA to $57 From $45, Maintains Outperform Rating - marketscreener.com
Raymond James Financial, Inc. $RJF Shares Bought by Fisher Asset Management LLC - MarketBeat
Raymond James upgrades Tectonic Therapeutics stock rating on pipeline potential - Investing.com
Raymond James downgrades BridgeBio Pharma stock rating on payer risks By Investing.com - Investing.com Canada
Raymond James Upgrades American Homes (AMH) to Outperform - Yahoo Finance
Finanzdaten der Raymond James Financial Inc-Aktie (RJF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):